Cargando…
Design of the Optimal Trial of Combination Therapy
Patients who take levothyroxine monotherapy to treat hypothyroidism frequently experience residual symptoms despite TSH testing at target levels. Trials have been conducted to evaluate the potential benefit of combination therapy with levothyroxine and liothyronine, though results have not consisten...
Autor principal: | Cappola, Anne R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146056/ https://www.ncbi.nlm.nih.gov/pubmed/32318021 http://dx.doi.org/10.3389/fendo.2020.00168 |
Ejemplares similares
-
Editorial: Combination Therapy for Hypothyroidism: The Journey From Bench to Bedside
por: Jonklaas, Jacqueline, et al.
Publicado: (2020) -
Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism
por: Gencer, Baris, et al.
Publicado: (2022) -
Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design
por: Madan, Ritu, et al.
Publicado: (2020) -
Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function
por: DiStefano, Joseph, et al.
Publicado: (2019) -
Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design
por: Premawardhana, Lakdasa D., et al.
Publicado: (2023)